Wealthcare Advisory Partners LLC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
Wealthcare Advisory Partners LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2021$505,000
+7.4%
62,1870.0%0.03%
+6.5%
Q2 2021$470,000
-13.0%
62,1870.0%0.03%
-20.5%
Q1 2021$540,000
+8.9%
62,1870.0%0.04%
-11.4%
Q4 2020$496,0000.0%62,1870.0%0.04%
-18.5%
Q3 2020$496,000
-19.5%
62,1870.0%0.05%
-29.9%
Q2 2020$616,000
+28.1%
62,1870.0%0.08%
+8.5%
Q1 2020$481,000
+100.4%
62,187
-0.1%
0.07%
+129.0%
Q4 2019$240,000
-23.3%
62,2790.0%0.03%
-31.1%
Q3 2019$313,000
-23.7%
62,279
+0.3%
0.04%
-30.8%
Q2 2019$410,000
-12.8%
62,0790.0%0.06%
-18.8%
Q1 2019$470,000
-6.4%
62,0790.0%0.08%
-17.5%
Q4 2018$502,000
-37.3%
62,0790.0%0.10%
-34.0%
Q3 2018$801,000
+13.1%
62,0790.0%0.15%
+5.8%
Q2 2018$708,000
+61.6%
62,0790.0%0.14%
+40.4%
Q1 2018$438,000
+14.4%
62,079
+5.4%
0.10%
+1.0%
Q4 2017$383,000
+4.9%
58,8990.0%0.10%
-9.3%
Q3 2017$365,00058,8990.11%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
CM Management, LLC 450,000$846,0000.90%
Skylands Capital, LLC 2,944,670$5,535,9800.84%
Sargent Investment Group, LLC 1,257,048$2,363,2500.57%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 197,940$372,1270.52%
Avenir Corp 2,717,397$5,108,7060.48%
Granahan Investment Management 1,552,393$2,918,4990.10%
Seelaus Asset Management LLC 20,450$38,4460.04%
HighMark Wealth Management LLC 10,000$18,8000.02%
Key Client Fiduciary Advisors, LLC 13,000$24,4400.02%
Eudaimonia Partners, LLC 23,500$44,1800.01%
View complete list of CYTOSORBENTS CORP shareholders